ecqm.unions

No Antithrombotic Ordered Union

Description:

Based On: Union87

Used By:

• CMS72v7

QDM Attributes

AntithromboticTherapyAdministered

Clinical Focus: This set of values contains anticoagulant and antiplatelet drugs used to reduce stroke mortality and morbidity.

Data Element Scope: The intent of this data element is to identify patients who receive antithombotic therapy following stroke. Using the Quality Data Model, this particular element would map to the Medication category.

Inclusion Criteria: Include single and multi-ingredient drugs. Oral, rectal, and injectable dose forms should be included. Antithrombotic medications include anticoagulants and antiplatelet drugs.

Exclusion Criteria: Exclude enoxaparin and heparin codes generally given for VTE prophylaxis.

Subject constrained to the Antithrombotic Therapy

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

AntithromboticTherapyAdministered

0..*

AntithromboticTherapyDischarge

Clinical Focus: This set of values contains anticoagulant and antiplatelet drugs used to reduce stroke mortality and morbidity.

Data Element Scope: The intent of this data element is to identify patients who receive antithombotic therapy following stroke. Using the Quality Data Model, this particular element would map to the Medication category.

Inclusion Criteria: Include single and multi-ingredient drugs. Oral, rectal, and injectable dose forms should be included. Antithrombotic medications include anticoagulants and antiplatelet drugs.

Exclusion Criteria: Exclude enoxaparin and heparin codes generally given for VTE prophylaxis.

Subject constrained to the Antithrombotic Therapy

MedicationDischarge: Data elements that meet criteria using this datatype should document that the medications indicated by the QDM category and its corresponding value set should be taken by or given to the patient after being discharged from an inpatient encounter. Timing: The time the discharge medication list on the discharge instruction form is authored.

DataType

Cardinality

AntithromboticTherapyDischarge

0..*

AntithromboticTherapyOrder

Clinical Focus: This set of values contains anticoagulant and antiplatelet drugs used to reduce stroke mortality and morbidity.

Data Element Scope: The intent of this data element is to identify patients who receive antithombotic therapy following stroke. Using the Quality Data Model, this particular element would map to the Medication category.

Inclusion Criteria: Include single and multi-ingredient drugs. Oral, rectal, and injectable dose forms should be included. Antithrombotic medications include anticoagulants and antiplatelet drugs.

Exclusion Criteria: Exclude enoxaparin and heparin codes generally given for VTE prophylaxis.

Subject constrained to the Antithrombotic Therapy

MedicationOrder: Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set. Timing: The Author dateTime is the time the order is signed. Timing: The Relevant Period addresses: startTime = when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed). stopTime = when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills. Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills). Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

AntithromboticTherapyOrder

0..*